drugset
drugset / Trial / NCT05240755

Effectiveness of Cannabidiol vs. Narcotics for Post Operative Pain Control in Elective Shoulder Arthroscopic Surgery

NCT05240755 ↗

Phase 0 Completed 40 enrolled Foundation for Orthopaedic Research and Education
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is a prospective, randomized, nonblinded trial to evaluate the effectiveness of Cannabidiol (CBD) oil on post-operative pain control compared to opioid medications.

Timeline

Start
2022-07-01
Primary completion
2024-06-20
Completion
2024-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 100 mg Oral
Subject Cannabidiol Other / unclassified 200 mg Oral

Indications

No indication recorded.